Antiretroviral News and Research

RSS

Two new studies develop algorithms to identify patients at risk of acquiring HIV

Two new studies developed algorithms that can identify patients who are at risk of acquiring HIV and may benefit from preventive care. Both studies appear in the July 5 issue of The Lancet HIV.

8 Jul 2019

Mice cured of HIV in an experiment sparks new hope

HIV is a viral infection that leads to AIDS and is fatal in almost all cases. For decades now, researchers have been trying to find a complete cure for this infection that affects 37 million people across the globe.

4 Jul 2019

Researchers completely eliminate all traces of HIV from infected mice

For the first time, researchers have successfully removed HIV-1 DNA from the genomes of living animals, a critical step towards a potential cure for the disease.

4 Jul 2019

Large prevention trial launched for people exposed to multidrug-resistant tuberculosis

A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis has begun.

25 Jun 2019

NIH offers $377,971 grant to develop disposable HIV-1 viral load microchip

As of 2017, about 36.9 million people around the world were living with HIV-- 1 in 4 were unaware of their HIV status.

21 Jun 2019

Invasive cervical cancer rates are high among women with HIV in South Africa, Latin America

A new International Journal of Cancer study indicates that rates of invasive cervical cancer are particularly high in women living with HIV in South Africa or Latin America.

19 Jun 2019

Study emphasizes need for better education to improve health care for LGBTQ

A first-of-its-kind survey of American neurologists reveals that more than half carry the mistaken belief that a patient's sexual orientation and gender identity have no bearing on treatment of neurologic illness.

18 Jun 2019

Long-acting contraceptives do not increase risk of HIV, concludes new study

One of the largest and most robust studies on HIV infection rates has concluded that long-acting contraceptives do not increase the risk of contracting HIV.

14 Jun 2019

Russian researcher announces plans to create more CRISPR-edited babies

A researcher has announced controversial plans to create gene-edited babies, dividing the scientific community.

12 Jun 2019

Study finds significant increases in rapid ART initiation after adoption of WHO’s ‘Treat All’ policy

A new study published in PLoS Medicine found that the adoption of the World Health Organization's 2015 "Treat All" recommendation was followed by large increases in rapid initiation of antiretroviral therapy (ART) in six sub-Saharan African countries.

12 Jun 2019

NIH awards $23 million grant to study the diseases affecting people with HIV

The National Institutes of Health has awarded a seven-year, $23 million grant to researchers at Albert Einstein College of Medicine and Montefiore Health System to study HIV and the chronic illnesses that often accompany HIV infection, including cardiovascular and lung disease, diabetes, and cancer.

8 Jun 2019

People living with HIV have increased risk for heart diseases and face health challenges

Effective antiretroviral therapy has changed the human immunodeficiency virus (HIV) from a progressive, fatal disease to a chronic, manageable condition that is associated with higher rates of heart attacks, strokes, heart failure, sudden cardiac deaths, and other diseases compared to people without HIV, according to a new scientific statement from the American Heart Association published in the Association journal Circulation.

3 Jun 2019

University of Miami establishes AIDS Research Center to curb HIV epidemic

The United Nation's goal of ending AIDS around the world by 2030 is undeniably ambitious, but within tantalizing reach.

23 May 2019

HIV treatment via community-based clubs can reduce retention of patients in care, study finds

Delivery of antiretroviral HIV treatment via community-based clubs can reduce retention of patients in care, according to a new research study published in the open-access journal PLOS Medicine by Colleen Hanrahan of the Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland and colleagues.

22 May 2019

Longer-acting, injectable HIV treatments on the horizon

An HIV diagnosis was once a death sentence, but now people who receive treatment survive for decades with the disease. Keeping the virus at bay usually requires taking a pill every day, which aside from being inconvenient for some, is an unwelcome daily reminder of the disease.

16 May 2019

New clinical trial to compare effectiveness of injectable drugs and oral medications to treat HIV

Researchers at the University of Colorado Anschutz Medical Campus, working with the National Institutes of Health, will conduct a clinical trial beginning this month to determine if monthly injections of anti-viral drugs are more effective at suppressing the HIV virus than daily pills in a population for whom daily adherence has been a challenge.

10 May 2019

Study evaluates long-acting HIV therapy in patients unable to adhere to strict daily regimens

A clinical trial to evaluate long-acting antiretroviral therapy for maintaining HIV suppression in people for whom adhering to conventional daily oral ART has been a challenge has begun at research sites across the United States.

9 May 2019

Better training needed for internal medicine residents to combat HIV epidemic, survey suggests

The nation's HIV epidemic remains stubbornly persistent, with almost 40,000 new infections annually in the United States.

8 May 2019

Immediate HIV treatment initiation has improved but not yet universal in NYC, study finds

A new study published in the Journal of Infectious Diseases found that immediate treatment initiation for HIV infection has improved since local and federal guidelines began to recommend universal treatment for all persons diagnosed with HIV, regardless of their disease stage.

7 May 2019

Stop the stigma: 'HIV transmission with suppressive ART is zero'

A new study has provided further evidence that taking antiretroviral therapy (ART) reduces the risk of HIV being transmitted between gay couples to effectively zero.

3 May 2019